(-)-Epigallocatechin-3-Gallate Ameliorates Atherosclerosis and Modulates Hepatic Lipid Metabolic Gene Expression in Apolipoprotein E Knockout Mice: Involvement of TTC39B

• Main Authors: Wei Wang (Author), Zheng-Zhu Zhang (Author), Yan Wu (Author), Ru-Qing Wang (Author), Jin-Wu Chen (Author), Jing Chen (Author), Yan Zhang (Author), Ya-Jun Chen (Author), Ming Geng (Author), Zhong-Dong Xu (Author), Min Dai (Author), Jin-Hua Li (Author), Li-Long Pan (Author)
• Format: Book
• Published: Frontiers Media S.A., 2018-03-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Aberrant chronic inflammation and excess accumulation of lipids play a pivotal role in the occurrence and progression of atherosclerosis. (-)-Epigallocatechin-3-gallate (EGCG), the major catechins in green tea, displayed anti-atherosclerotic properties in vivo and in vitro. However, the...